Cheryl Lassen

Once-daily indacaterol<i>versus</i>twice-daily salmeterol for COPD: a placebo-controlled comparison

Oliver Kornmann, Ronald Dahl, Stefano Centanni et al. · European Respiratory Journal · 2010 · 213 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison

Donald A. Mahler, Anthony D’Urzo, Eric Bateman et al. · Thorax · 2012 · 154 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +16

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

Roland Buhl, Leonard Dunn, Carlos Disdier et al. · European Respiratory Journal · 2011 · 140 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD

Kenneth R. Chapman, Stephen I. Rennard, Roger Owen et al. · CHEST Journal · 2011 · 124 citations

Medicine, Pharmacology, Pharmacotherapy +13

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study

Stephanie Korn, Edward Kerwin, Carolynn Amos et al. · Respiratory Medicine · 2011 · 97 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +6